Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06402773 · ClinicalTrials.gov registry record · NA
A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy
A NA study of Vasectomy, sponsored by Signati Medical.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06402773 is a NA study of Vasectomy that has completed, run by Signati Medical. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06402773, a NA study of Vasectomy, has completed, sponsored by Signati Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Signati SeparoTM System when used in general surgical procedures where ligation and division of vessels are desired, such as the vas deferens. This study will evaluate the Signati SeparoTM System as a vasectomy device.
Conditions Studied
Interventions
- DEVICE The Signati Separo™ Vessel Sealing System
Study Locations (1)
Louisiana
- LSU Health - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06402773
The ClinicalTrials.gov registry entry for NCT06402773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Signati Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vasectomy appearing as the primary indexed condition, and to 1 intervention - of which The Signati Separo™ Vessel Sealing System is the first listed.
NCT06402773 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06402773 about?
NCT06402773 is a clinical study titled "A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy". The purpose of this study is to evaluate the safety and effectiveness of the Signati SeparoTM System when used in general surgical procedures where ligation and division of vessels are desired, such as the vas deferens. This study will evaluate the Signati SeparoTM System as a vasectomy device.
What is the current status of trial NCT06402773?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-04-05. Estimated completion is 2024-12-30.
What conditions does trial NCT06402773 study?
This clinical trial studies the following conditions: Vasectomy.
What interventions are being tested in trial NCT06402773?
The interventions under investigation include: The Signati Separo™ Vessel Sealing System (DEVICE).
Who is sponsoring clinical trial NCT06402773?
This trial is sponsored by Signati Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06402773 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.